A Phase 1 Study of Cizutamig in IgE Mediated Diseases
NCT07408869
·
clinicaltrials.gov ↗
PHASE1
Phase
NOT_YET_RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
IgE-Mediated Hypersensitivity
IgE Mediated Food Allergy
IgE-Mediated Cow Milk Allergy
Interventions
BIOLOGICAL:
Cizutamig
Sponsor
Candid Therapeutics